Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Zhenhua Wu
Observed name:
Zhen-hua Wu
Institutions:
Shanghai Medical College of Fudan University,
Fudan University,
Fudan University Shanghai Cancer Center
Observed institutions:
Ningbo University,
Shanghai Medical College of Fudan University,
Xinjiang Medical University,
Fudan University,
Fudan University Shanghai Cancer Center,
Tumor Hospital of Xinjiang Medical University,
Ningbo Medical Center Lihuili Hospital
show all 7
ORCID:
0009-0006-7109-7315
Observed ORCID:
0009-0006-7109-7315
OpenAlex ID:
A5112138634
Invasive Sino‐orbital‐skull Base Aspergillosis Progressing from Aspergillus Ball of Maxillary Sinus: A Case Report
2017
·
Qi Huang
, Kan Zhao
, et al.
·
OTO Open
·
4
PDF
To verify the biological characteristics of disulfidptosis associated gene ADORA2B in esophageal cancer
2025
·
Yixiao Cui
, Yuhan Deng
, et al.
·
BMC Gastroenterology
·
3
PDF
CH25H Promotes Autophagy and Regulates the Malignant Progression of Laryngeal Squamous Cell Carcinoma Through the PI3K ‐ AKT Pathway
2024
·
Zhenfei Xiang
, Senquan Yu
, et al.
·
Cancer Medicine
·
3
Small extracellular vesicle miRNAs as biomarkers for predicting antitumor efficacy in lung adenocarcinoma treated with chemotherapy and checkpoint blockade
2025
·
Si Sun
, Fuchuang Zhang
, et al.
·
Frontiers in Immunology
·
2
Amivantamab in EGFR -mutated NSCLC with refractory brain or leptomeningeal metastases: A multi-center real-world study.
2026
·
Chang Lu
, Meng-Hang Yang
, et al.
·
Journal of Clinical Oncology
·
1
Evaluation of gefitinib alone or combined with bevacizumab in patients with EGFR L858R-positive advanced non-squamous non-small cell lung cancer: an open-label, randomized, phase 2 trial (BEVA-FLFX-001) with exploratory analysis of plasma biomarkers
2025
·
Xinmin Zhao
, Xianghua Wu
, et al.
·
Translational Lung Cancer Research
·
1
Irinotecan liposome combined with anlotinib as second-line treatment in patients with small cell lung cancer (SCLC).
2025
·
Jialei Wang
, Yina Wang
, et al.
·
Journal of Clinical Oncology
·
1
An LNM-Associated Gene Signature for Prognostic Prediction and Immune Profiling in Head and Neck Squamous Cell Carcinoma
2025
·
Zhenzhen Wang
, Zhenhua Wu
, et al.
·
Cancer Biotherapy and Radiopharmaceuticals
·
1
Bevacizumab plus nab‐paclitaxel and platinum as second‐line therapy for driver‐gene‐negative non‐squamous non‐small cell lung cancer after immunochemotherapy: A prospective single‐arm single‐centre study
2026
·
Ying Lin
, Yunbo Yu
, et al.
·
Clinical and Translational Medicine
PDF
68Ga-granzyme B (68Ga-NOTA-GSI) PET/CT for predicting immunotherapy response and progression free survival in NSCLC
2026
·
Ziyi Yang
, Zhihuang Hu
, et al.
·
European Journal of Nuclear Medicine and Molecular Imaging
Firmonertinib combined with platinum-based chemotherapy in patients with EGFR -mutant advanced NSCLC following disease progression on first-line third-generation EGFR-TKI.
2026
·
Jialei Wang
, Hui Yu
, et al.
·
Journal of Clinical Oncology
PDF
Single-cell RNA sequencing reveals FOLR2+ macrophages interaction with HSPA6+ NSCLC cells via CCL2/ICAM-1 in malignant pleural effusion and promotes EGFR-TKI resistance
2026
·
Zhenhua Wu
, Xin Zhang
, et al.
·
Genes & Diseases
Abstract 743: A prognostic model based on plasma proteomics for predicting immuno-chemotherapy outcomes in advanced non-small cell lung cancer
2025
·
Zhihuang Hu
, Jialei Wang
, et al.
·
Cancer Research
[Endoscopic three minus septoplasty].
2010
·
Xing-you Zhang
, Zhen-hua Wu
, et al.
·
PubMed
Show more works
View as search
Works count:
14
Citation count:
16
H-index:
3
I10-index:
Year
Topic
Type